A Phase II trial of a new monoclonal antibody drug shows promise for a potential new treatment for lupus.
American College of Rheumatology (ACR) 2015 annual meeting
Rheumatologists and staff should communicate about coding, says ACR’s Melesia Tillman who offers an ICD-10 recap post ACR/ARHP 2015.
Men and women with incident bone fractures face increased mortality by two, but even higher for those with proximal fractures.
Women can reduce their risk of developing rheumatoid arthritis by eating a healthy diet, study presented at 2015 ACR/ARHP shows.
Achieving sustained remission in early rheumatoid arthritis is less likely for overweight and obese patients as compared to thinner counterparts.
Adalimumab improves function and quality of life for patients with uveitis, shows a study presented at 2015 ACR/ARHP.
IL-6 inhibitors sarilumab, an investigational drug, and tocilizumab, an established treatment in RA, are equally safe, shows two studies presented at ACR/ARHP 2015.
Certolizumab pegol with methotrexate leads to impressive outcomes for early rheumatoid arthritis patients, shows study presented at 2015 ACR/ARHP.
In this interview, Herbert S. B. Baraf, MD, FACP, MACR, provides his take-a-ways from ACR/ARHP 2015 about new reimbursement policies affecting private practice rheumatologists.
Disability-accommodating workplace policies can help workers with arthritis stay in jobs longer and can lead to enhanced job performance.